Scarica l'app Stockscreener
2.21
7.14%
-0.17
Pre-mercato:
2.23
0.02
+0.90%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.38
Aprire:
$2.38
Volume 24 ore:
922.19K
Relative Volume:
0.57
Capitalizzazione di mercato:
$147.02M
Reddito:
$488.00K
Utile/perdita netta:
$-41.44M
Rapporto P/E:
-2.3763
EPS:
-0.93
Flusso di cassa netto:
$-31.47M
1 W Prestazione:
+0.91%
1M Prestazione:
+8.33%
6M Prestazione:
-7.14%
1 anno Prestazione:
-12.30%
Intervallo 1D:
$2.21
$2.385
Intervallo di 1 settimana:
$2.1508
$2.47
Portata 52W:
$1.90
$5.6395
Cardiff Oncology Inc Stock (CRDF) Company Profile
Nome
Cardiff Oncology Inc
Settore
Industria
Telefono
858-952-7570
Indirizzo
11055 FLINTKOTE AVENUE, SAN DIEGO, CA
Confronta CRDF con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRDF
Cardiff Oncology Inc
|
2.21 | 158.33M | 488.00K | -41.44M | -31.47M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cardiff Oncology Inc Stock (CRDF) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-08 | Iniziato | Ladenburg Thalmann | Buy |
| 2025-06-24 | Iniziato | Jefferies | Hold |
| 2024-09-06 | Iniziato | Craig Hallum | Buy |
| 2022-01-05 | Iniziato | William Blair | Outperform |
| 2021-12-08 | Iniziato | Robert W. Baird | Outperform |
| 2021-08-09 | Ripresa | Maxim Group | Buy |
| 2020-10-22 | Iniziato | H.C. Wainwright | Buy |
| 2020-10-08 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Cardiff Oncology Inc Borsa (CRDF) Ultime notizie
Does Cardiff Oncology Inc. fit your quant trading model2025 Price Momentum & Consistent Growth Stock Picks - newser.com
What technical signals suggest for Cardiff Oncology Inc. stockWeekly Gains Report & Fast Exit Strategy with Risk Control - newser.com
Blair William & Co. IL Grows Position in Cardiff Oncology, Inc. $CRDF - MarketBeat
Cardiff Oncology to Present at Upcoming Investor Conferences in September - GuruFocus
Is a relief rally coming for Cardiff Oncology Inc. holdersBull Run & Risk Controlled Stock Pick Alerts - newser.com
Analyzing recovery setups for Cardiff Oncology Inc. investorsQuarterly Portfolio Review & AI Driven Price Predictions - newser.com
Measuring Cardiff Oncology Inc.’s beta against major indices2025 Market WrapUp & Scalable Portfolio Growth Ideas - newser.com
Using AI based signals to follow Cardiff Oncology Inc.July 2025 Review & Real-Time Chart Breakout Alerts - newser.com
Why Cardiff Oncology Inc. stock remains resilientJuly 2025 Movers & AI Based Buy and Sell Signals - newser.com
Weiss Ratings Reiterates "Sell (D-)" Rating for Cardiff Oncology (NASDAQ:CRDF) - MarketBeat
Cardiff Oncology at Noble Capital: Promising Results for Onvansertib By Investing.com - Investing.com Canada
Bullish Cardiff Oncology Insiders Loaded Up On US$1.72m Of Stock - simplywall.st
What MACD signals say about Cardiff Oncology Inc.Watch List & Trade Opportunity Analysis Reports - newser.com
Is Cardiff Oncology Inc. a candidate for recovery playMarket Performance Recap & AI Driven Stock Price Forecasts - newser.com
Brokerages Set Cardiff Oncology, Inc. (NASDAQ:CRDF) PT at $10.63 - Defense World
Is Cardiff Oncology Inc a good long term investmentMarket Profile Overview & Watch These Before They Go Viral - earlytimes.in
Can Exhicon Events Media Solutions Limited Achieve Revenue Diversification SuccessfullyMarket Timing Techniques & Affordable Market Strategies - earlytimes.in
How supply shortages influence Cardiff Oncology Inc. (XE7C) stockWall Street Watch & Safe Capital Growth Tips - newser.com
Tools to assess Cardiff Oncology Inc.’s risk profile2025 Growth vs Value & Real-Time Volume Triggers - newser.com
Cardiff Oncology, Inc. (NASDAQ:CRDF) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
What technical models suggest about Cardiff Oncology Inc.’s comeback2025 Stock Rankings & Free Real-Time Volume Trigger Notifications - newser.com
Cardiff Oncology to Participate in Two Upcoming Investor Conferences - GlobeNewswire
Will Cardiff Oncology Inc. benefit from macro trendsEarnings Performance Report & AI Powered Market Entry Strategies - newser.com
Two Oct. 9 investor presentations: Cardiff Oncology management to appear; webcast replay in 48 hours - Stock Titan
What analysts say about Cardiff Oncology Inc XE7C stockEquity Performance Review & Machine Learning Stock Picks, Daily - earlytimes.in
Cardiff Oncology Inc Azioni (CRDF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cardiff Oncology Inc Azioni (CRDF) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| PACE GARY W | Director |
Jul 30 '25 |
Buy |
2.45 |
15,000 |
36,750 |
1,345,676 |
| Levine James E. | Chief Financial Officer |
Dec 17 '24 |
Buy |
5.42 |
2,752 |
14,905 |
65,316 |
| Levine James E. | Chief Financial Officer |
Dec 18 '24 |
Buy |
5.00 |
2,400 |
12,000 |
67,716 |
| Levine James E. | Chief Financial Officer |
Dec 16 '24 |
Buy |
3.83 |
2,564 |
9,820 |
62,564 |
| TANNENBAUM RENEE P | Director |
Dec 12 '24 |
Buy |
3.42 |
10,000 |
34,224 |
20,000 |
| PACE GARY W | Director |
Dec 11 '24 |
Buy |
2.60 |
350,115 |
910,299 |
1,047,876 |
| PACE GARY W | Director |
Dec 11 '24 |
Buy |
2.60 |
11,500 |
29,900 |
1,059,376 |
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):